Partner Eric Furman, Ph.D., was quoted in, “A Closer Look at the Legal Aspects of Patents in the Cannabis Industry,” an article published by Cannabis Science and Technology.
Excerpt: With the recent approval of Epidiolex by the US Food & Drug Administration and the rescheduling of cannabidiol (CBD) by the U.S. Drug Enforcement Administration, we can expect an increased interest in cannabis-derived drugs and formulations.
